tiprankstipranks
DMK Pharmaceuticals Annual Stockholders’ Meeting Outcomes
PremiumCompany AnnouncementsDMK Pharmaceuticals Annual Stockholders’ Meeting Outcomes
3M ago
DMK Pharmaceuticals Regains Full Rights to Commercialize ZIMHI
PremiumPress Releases
DMK Pharmaceuticals Regains Full Rights to Commercialize ZIMHI
4M ago
DMK Pharmaceuticals regains full rights to commercialize ZIMHI
PremiumThe Fly
DMK Pharmaceuticals regains full rights to commercialize ZIMHI
4M ago
DMK Pharmaceuticals Announces Presentation of Preclinical Results Comparing Effects of DPI-125 on Opioid Withdrawal Behaviors Versus Standard of Care for Opioid Use Disorder at SfN Neuroscience 2023
PremiumPress ReleasesDMK Pharmaceuticals Announces Presentation of Preclinical Results Comparing Effects of DPI-125 on Opioid Withdrawal Behaviors Versus Standard of Care for Opioid Use Disorder at SfN Neuroscience 2023
6M ago
DMK Pharmaceuticals reports preclinical results on DPI-125
PremiumThe Fly
DMK Pharmaceuticals reports preclinical results on DPI-125
6M ago
DMK Pharmaceuticals announces inducement option grant
PremiumThe Fly
DMK Pharmaceuticals announces inducement option grant
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100